A new episode of Health Matters, a podcast presented by Wellmark Blue Cross and Blue Shield, launches this week, with the focus on pharmacy biosimilars. Listen to the latest episode now.
Pharmacy spend continues to grow, especially with the rising cost of specialty medications. At Wellmark Blue Cross and Blue Shield, we work both internally and with employers to explore and implement a variety of approaches to offset cost pressures. In this episode, Jace Engstler, senior clinical account consultant, and Ryan Nulty, associate clinical account consultant, discuss Wellmark’s approach to biosimilars. Specifically, the what and why of biosimilars, and the value their use brings to our members and employers.
Listen now to this episode of Health Matters as our Wellmark experts discuss:
- What are biologics and biosimilars
- What is the value of moving to a biosimilar
- How Wellmark determines when to switch to a biosimilar
- How safe are biosimilars
- What does the transition look like for members
